Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawn C Matthews

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Neurology|April 15, 2018
Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adultsValentina Berti, Michelle Walters, Joanna Sterling, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 25, 2025
EC<sub>50</sub> images reveal reproducible spatial variation in drug affinity across single- and repeat-dose occupancy studiesAlaaddin Ibrahimy, Su Jin Kim, Mark E Schmidt, et al.
Brain Communications|April 14, 2026
Plasma p-tau217 and glucose metabolism correlate in neocortical association areas in Alzheimer's diseaseLauren N Koenig, Hanna Huber, Anjalika Chongtham, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 22, 2021
Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementiaDawn C Matthews, Aaron Ritter, Ronald G Thomas, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 24, 2017
Dissociation of Down syndrome and Alzheimer's disease effects with imagingDawn C Matthews, Ana S Lukic, Randolph D Andrews, et al.
Plos One|January 13, 2025
Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer's diseaseMatilde Nerattini, Schantel Williams, Caroline Andy, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2025
Quantitative and simplified [18F] fluoroestradiol positron emission tomography (PET) measures of brain estrogen receptor expressionMatilde Nerattini, Valentina Berti, Dawn C Matthews, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 11, 2024
Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patientsDawn C Matthews, Jefferson W Kinney, Aaron Ritter, et al.
Brain : a Journal of Neurology|June 19, 2021
Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's diseaseDawn C Matthews, Xiangling Mao, Kathleen Dowd, et al.
Scientific Reports|June 20, 2024
In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatologyLisa Mosconi, Matilde Nerattini, Dawn C Matthews, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Neurology|April 15, 2018
Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adultsValentina Berti, Michelle Walters, Joanna Sterling, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 25, 2025
EC<sub>50</sub> images reveal reproducible spatial variation in drug affinity across single- and repeat-dose occupancy studiesAlaaddin Ibrahimy, Su Jin Kim, Mark E Schmidt, et al.
Brain Communications|April 14, 2026
Plasma p-tau217 and glucose metabolism correlate in neocortical association areas in Alzheimer's diseaseLauren N Koenig, Hanna Huber, Anjalika Chongtham, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 22, 2021
Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementiaDawn C Matthews, Aaron Ritter, Ronald G Thomas, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 24, 2017
Dissociation of Down syndrome and Alzheimer's disease effects with imagingDawn C Matthews, Ana S Lukic, Randolph D Andrews, et al.
Plos One|January 13, 2025
Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer's diseaseMatilde Nerattini, Schantel Williams, Caroline Andy, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2025
Quantitative and simplified [18F] fluoroestradiol positron emission tomography (PET) measures of brain estrogen receptor expressionMatilde Nerattini, Valentina Berti, Dawn C Matthews, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 11, 2024
Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patientsDawn C Matthews, Jefferson W Kinney, Aaron Ritter, et al.
Brain : a Journal of Neurology|June 19, 2021
Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's diseaseDawn C Matthews, Xiangling Mao, Kathleen Dowd, et al.
Scientific Reports|June 20, 2024
In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatologyLisa Mosconi, Matilde Nerattini, Dawn C Matthews, et al.
Pageof 3